Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP498850.RALNnImVcw6gJFpMFK2gSeWWceKNMiE-oI9btj5QrY1BM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP498850.RALNnImVcw6gJFpMFK2gSeWWceKNMiE-oI9btj5QrY1BM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP498850.RALNnImVcw6gJFpMFK2gSeWWceKNMiE-oI9btj5QrY1BM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP498850.RALNnImVcw6gJFpMFK2gSeWWceKNMiE-oI9btj5QrY1BM130_provenance.
- NP498850.RALNnImVcw6gJFpMFK2gSeWWceKNMiE-oI9btj5QrY1BM130_assertion description "[The glucose-lowering effects of glucagon peptide antagonists and antiglucagon neutralising antibodies first demonstrated the potential of glucagon receptor (GCGR) antagonism as a treatment for hyperglycaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498850.RALNnImVcw6gJFpMFK2gSeWWceKNMiE-oI9btj5QrY1BM130_provenance.
- NP498850.RALNnImVcw6gJFpMFK2gSeWWceKNMiE-oI9btj5QrY1BM130_assertion evidence source_evidence_literature NP498850.RALNnImVcw6gJFpMFK2gSeWWceKNMiE-oI9btj5QrY1BM130_provenance.
- NP498850.RALNnImVcw6gJFpMFK2gSeWWceKNMiE-oI9btj5QrY1BM130_assertion SIO_000772 15948676 NP498850.RALNnImVcw6gJFpMFK2gSeWWceKNMiE-oI9btj5QrY1BM130_provenance.
- NP498850.RALNnImVcw6gJFpMFK2gSeWWceKNMiE-oI9btj5QrY1BM130_assertion wasDerivedFrom befree-2016 NP498850.RALNnImVcw6gJFpMFK2gSeWWceKNMiE-oI9btj5QrY1BM130_provenance.
- NP498850.RALNnImVcw6gJFpMFK2gSeWWceKNMiE-oI9btj5QrY1BM130_assertion wasGeneratedBy ECO_0000203 NP498850.RALNnImVcw6gJFpMFK2gSeWWceKNMiE-oI9btj5QrY1BM130_provenance.
- befree-2016 importedOn "2016-02-19" NP498850.RALNnImVcw6gJFpMFK2gSeWWceKNMiE-oI9btj5QrY1BM130_provenance.